Latest Blog Posts
Search
Sort Results
Filter by Programming
Filter by Specific Population
Filter by Topic
- Organ and body health (51)
- Disease progression (15)
- Reproductive and maternal health (15)
- Emotional health (12)
- Infections and cancers (12)
- Prevention interventions (10)
- Social determinants of health (5)
- Healthy living (3)
- Testing and diagnosis (3)
- Government and community strategies (2)
- Harm reduction and substance use (2)
- Monitoring tests (2)
- Legal issues and human rights (1)
- Safer sex and sexual health (1)
- Transmission and risk (1)
Filter by Infection
Search results
Current filters: HIV, Treatment, English
328 search results
- Fostemsavir compassionate access program
-
From TreatmentUpdate 234
2019, CATIE
Research summary - Webpage - Fostemsavir in treatment-experienced people
-
From TreatmentUpdate 234
2019, CATIE
Research summary - Webpage - The debut of fostemsavir
-
From TreatmentUpdate 234
2019, CATIE
Research summary - Webpage - Doravirine begins to be listed on formularies
-
From TreatmentUpdate 234
2019, CATIE
Research summary - Webpage - Montreal researchers explore cannabis use among people with HIV and hepatitis C
-
2019, CATIE
Research summary - Webpage - Decreasing the risk of neural tube defects with dolutegravir
-
From TreatmentUpdate 233
2019, CATIE
Research summary - Webpage - More dual HIV regimens are coming
-
From TreatmentUpdate 233
2019, CATIE
Research summary - Webpage - Some issues to consider with Dovato (dolutegravir + 3TC)
-
From TreatmentUpdate 233
2019, CATIE
Research summary - Webpage - Switching to Dovato (dolutegravir + 3TC) from a TAF-based regimen
-
From TreatmentUpdate 233
2019, CATIE
Research summary - Webpage - Dovato (dolutegravir + 3TC) in initial HIV treatment
-
From TreatmentUpdate 233
2019, CATIE
Research summary - Webpage
